CXCL10 and neoplasm: Oncolytic herpes simplex virus expressing CXCL10 (oHSV-CXCL10) utilises chemokine gradients to recruit peripheral NK cells while inducing tumour cells to release damage-associated molecular patterns, thereby amplifying ADCC.